Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma
Authors:
Open Access
- 22 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 24 (2) , 330-340
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative‐intent Surgery: A Multi‐institutional Study from the US Extrahepatic Biliary Malignancy ConsortiumWorld Journal of Surgery, 2018
- Preoperative lymphocyte-to-monocyte ratio as a strong predictor of survival and recurrence for gastric cancer after radical-intent surgeryOncotarget, 2017
- Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resectionLangenbeck's Archives of Surgery, 2016
- The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patientsMedical Oncology, 2014
- Hilar cholangiocarcinoma: diagnosis, treatment options, and management2014
- Management of perihilar cholangiocarcinoma in the era of multimodal therapyExpert Review of Gastroenterology & Hepatology, 2012
- Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US CentersGastroenterology, 2012
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Long-Term Outcome of Extended Hemihepatectomy for Hilar Bile Duct Cancer With No Mortality and High Survival RateAnnals of Surgery, 2003
- Systemic inflammatory response predicts survival following curative resection of colorectal cancerBritish Journal of Surgery, 2003